Improvement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study-Reference-Cited by-同舟云学术

Improvement of both fasting and postprandial glycemic control by the two-step addition of miglitol and mitiglinide to basal insulin therapy: a pilot study

Published:2014-03-31 Issue:1 Volume:6 Page:
ISSN:1758-5996
Container-title:Diabetology & Metabolic Syndrome
language:en
Short-container-title:Diabetol Metab Syndr

Author:

Ihana Noriko,Tsujimoto Tetsuro,Yamamoto-Honda Ritsuko,Kishimoto Miyako,Kajio Hiroshi,Noto Hiroshi,Kakei Masafumi,Noda Mitsuhiko

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1186/1758-5996-6-48.pdf

Reference34 articles.

1. The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int. 2010, 1: 2-20. 10.1007/s13340-010-0006-7.

2. Kosaka K, Kuzuya T, Hagura R, Yoshinaga H: Insulin response to oral glucose load is consistently decreased in established non-insulin-dependent diabetes mellitus: the usefulness of decreased early insulin response as a predictor of non-insulin-dependent diabetes mellitus. Diabet Med. 1996, 13: S109-S119.

3. Yamamoto-Honda R, Osame K, Kitazato H, Shinkai-Goromaru M, Isogawa A, Yoshida Y, Kawzu S, Akanuma Y, Noda M: Insulin secretion and insulin sensitivity in Japanese patients with Type 2 diabetes: a cross-sectional study comparing the homeostasis model assessment-2 (HOMA2) indexes and indexes derived from the oral glucose tolerance test. Diabetology Int. 2011, 2: 72-78. 10.1007/s13340-011-0024-0.

4. Holman RR, Thorne KI, Farmer AJ, Davies MJ, Keenan JF, Paul S, Levy JC, 4-T Study Group: Addition of Biphasic, Prandial, or Basal Insulin to Oral Therapy in Type 2 Diabetes. N Engl J Med. 2007, 357: 1716-1730. 10.1056/NEJMoa075392.

5. Bretzel RG, Nuber U, Landgraf W, Owens DR, Brandley C, Linn T, Bretzel A, Nuber U, Landgraf W, Owens DR, Brandley C, Linn T: Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomized controlled trial. Lancet. 2008, 371: 1073-1084. 10.1016/S0140-6736(08)60485-7.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of switching basal–bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an α-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching;Diabetology International;2023-09-04

2. Clinic-on-a-Needle Array toward Future Minimally Invasive Wearable Artificial Pancreas Applications;ACS Nano;2021-06-22

3. Gut-Based Strategies to Reduce Postprandial Glycaemia in Type 2 Diabetes;Frontiers in Endocrinology;2021-04-09

4. Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study;Journal of Diabetes Investigation;2021-02-05

5. Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus;Medical Science Monitor Basic Research;2017-02-28